About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Lactulose
- Procedure number
- PSUSA/00001821/202105
- Regulatory outcome
- Variation
Documents
Lactulose : List of nationally authorised medicinal products - PSUSA/00001821/202105
English (EN) (306.08 KB - PDF)
Lactulose : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00001821/202105
English (EN) (50.46 KB - PDF)
български (BG) (106.14 KB - PDF)
español (ES) (28.93 KB - PDF)
čeština (CS) (97.09 KB - PDF)
dansk (DA) (28.3 KB - PDF)
Deutsch (DE) (28.53 KB - PDF)
eesti keel (ET) (29.86 KB - PDF)
ελληνικά (EL) (95.78 KB - PDF)
français (FR) (22.84 KB - PDF)
hrvatski (HR) (87.77 KB - PDF)
íslenska (IS) (21.65 KB - PDF)
Gaeilge (GA) (24.55 KB - PDF)
italiano (IT) (25.54 KB - PDF)
latviešu valoda (LV) (94.17 KB - PDF)
lietuvių kalba (LT) (90.75 KB - PDF)
magyar (HU) (91.16 KB - PDF)
Malti (MT) (98.82 KB - PDF)
Nederlands (NL) (22.29 KB - PDF)
norsk (NO) (27.63 KB - PDF)
polski (PL) (92.9 KB - PDF)
português (PT) (23.76 KB - PDF)
română (RO) (92.57 KB - PDF)
slovenčina (SK) (97.29 KB - PDF)
slovenščina (SL) (87.32 KB - PDF)
Suomi (FI) (22.77 KB - PDF)
svenska (SV) (23.68 KB - PDF)